How this instrument works
Biologically Effective Dose converts a radiotherapy schedule, a number of fractions each delivering some dose in gray, into a single figure that accounts for how fraction size affects biological damage, not just the raw total. It comes from the linear-quadratic model of radiation cell killing, formalized by Fowler in 1989, and is the standard tool radiation oncologists use to compare schedules that split the same or different total doses into different-sized pieces.
The formula needs one more input beyond fractions and dose per fraction: the α⁄β ratio of the tissue being evaluated. Tumors and early-responding tissue such as skin or mucosa typically have a high α⁄β, around 10 Gy, meaning their damage scales fairly linearly with dose. Late-responding normal tissue such as spinal cord, lung, or connective tissue typically has a low α⁄β, around 3 Gy, meaning it is disproportionately sensitive to large individual fractions. Plugging the same physical course into the formula twice, once per tissue type, produces two different BED numbers from one course of treatment.
That is the entire point of the calculation: there is no single figure that is simply the BED for a treatment course, only a BED against a specified tissue. Radiation oncologists compute it against the tumor, wanting that number high for effective killing, and separately against nearby healthy tissue the beam also passes through, wanting that number low or at least within a tolerated limit, then compare the two to judge whether a schedule is a reasonable trade. Larger, fewer fractions, hypofractionation, tend to push both numbers up disproportionately, because each large fraction adds more to the dose-over-α⁄β term than a small one does, which is why modern hypofractionated protocols get checked against conventional schedules via BED rather than by comparing raw total dose alone.
- Enter Number of fractions — how many treatment sessions the course is split into.
- Enter Dose per fraction in gray (Gy) — the dose delivered at each session.
- Select the α⁄β ratio — 10 Gy for tumor or early-responding tissue, 3 Gy for late-responding normal tissue.
- Read Biologically Effective Dose in Gy; switch the α⁄β selection to compare the same course against a different tissue type.
Worked example — 30 fractions of 2 Gy, two tissue types
30 fractions of 2 Gy each is a total physical dose of 60 Gy. Against tumor tissue with α⁄β = 10: BED = 30 × 2 × (1 + 2/10) = 60 × 1.2 = 72 Gy. Against late-responding normal tissue with α⁄β = 3: BED = 30 × 2 × (1 + 2/3) = 60 × 1.667 = 100 Gy, the identical physical course giving two different biological numbers, because the 2 Gy fraction size interacts differently with each tissue's sensitivity.
Now compare a hypofractionated course: 5 fractions of 6 Gy each, only 30 Gy total, against the same tumor tissue with α⁄β = 10: BED = 5 × 6 × (1 + 6/10) = 30 × 1.6 = 48 Gy, less than the 72 Gy the 30-fraction course delivered, despite each individual fraction being three times larger, because the total physical dose here is half as much. Fraction size raises BED per gray delivered, but total dose still sets the scale.
Questions
Why does the same radiation course give two different BED numbers?
Because BED is calculated against a specific tissue's α⁄β ratio, and the ratio changes the answer. The physical dose delivered does not change, only which biological system you are scoring it against does. Radiation oncologists deliberately compute BED twice for the same schedule, once using the tumor's α⁄β, wanting that number high, and once using nearby healthy tissue's α⁄β, wanting that number low or tolerable. There is no single figure that is simply the BED for a course, only a BED against a named tissue.
What is the α⁄β ratio, in plain terms?
It is a tissue-specific number from the linear-quadratic model describing how sensitive that tissue is to fraction size. A high α⁄β, around 10 Gy, typical of tumors and fast-dividing tissue, means damage scales close to linearly with dose, so fraction size matters less. A low α⁄β, around 3 Gy, typical of late-responding tissue such as spinal cord or lung, means large individual fractions do disproportionately more damage than the same total dose split finer would.
Why does hypofractionation produce a bigger BED for the same total dose?
Because the formula's bracket term, 1 plus dose over α⁄β, grows with fraction size. Doubling the dose per fraction more than doubles that bracket's contribution, so fewer, larger fractions push BED up faster than the total physical dose alone would suggest. That is precisely why modern hypofractionated protocols, fewer visits, larger daily doses, need a BED-based comparison against conventional schedules, not a naive comparison of total gray delivered.
Should I use 10 Gy or 3 Gy for the α⁄β ratio?
Use 10 Gy when evaluating effect on the tumor or other early-responding, fast-dividing tissue, and 3 Gy when evaluating effect on late-responding normal tissue such as spinal cord, lung, or connective tissue that the beam also passes through. The two runs answer different questions, how well is this killing the tumor versus how much lasting damage is this doing nearby, and both matter for judging a schedule.
Is a higher BED always better?
Only when it is calculated against the tumor, where higher generally means more effective tumor control. Calculated against nearby healthy tissue, a higher BED is worse, meaning more biological damage to structures the treatment is meant to spare. Reading a BED number without knowing which tissue it was computed against tells you almost nothing; the number and the tissue always travel together.
Does BED account for treatment time or gaps between fractions?
Not in this basic form. The formula here, from Fowler's 1989 derivation, accounts for fraction size and total fraction count but assumes fractions are delivered on a standard schedule without unplanned gaps. Extended treatment-time corrections exist for cases like prolonged overall treatment duration, where tumor repopulation between fractions becomes a separate factor, but they sit outside this calculation.
References
- Fowler JF, 1989, Br J Radiol — linear-quadratic formula (PubMed)
- MDCalc — Radiation Biologically Effective Dose (BED) Calculator
Read this first: This instrument computes a screening figure from population formulas — it is not a diagnosis, and it cannot see the whole picture a clinician can. Use it to inform a conversation, not to replace one.